0HIY.LAtara Biotherapeutics Inc

Acerca de

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

www.atarabio.com

Estadísticas clave

Cap. de mercado

102.37M

BPA

2.61

Rend. dividendo

0.00%

Beta

0.11

P/VC

-5.86

ROE

-84.9%

Sector

Healthcare

Industria

Medical - Pharmaceuticals

CEO

Anhco Nguyen

Empleados

14

Fecha IPO

2018-01-29

País

US